Hung, Hing Yu
Song, Tianhe
Loo, Steven King Fan
Chan, Kam Leung
Ching, Jessica Yuet Ling
Sum, Chi Him
Lo, Louis Cho Wing
Chia, Sarah Chon Pin
Ho, Ray Tin Muk
Cheong, Pui Kuan
Siu, Tony Hon Chung
Leung, Ka Chun
Lin, Zhi-Xiu
Clinical trials referenced in this document:
Documents that mention this clinical trial
Efficacy and safety of modified Xiao-Feng Powder in the treatment of chronic urticaria: protocol of a randomized double-blind placebo-controlled study
https://doi.org/10.1186/s13020-022-00642-3
Funding for this research was provided by:
Dr. Barbara Kwok’s Fund for Integrative Medicine Research at the Hong Kong Institute of Integrative Medicine, CUHK.
Article History
Received: 7 April 2022
Accepted: 9 July 2022
First Online: 22 July 2022
Declarations
:
: The study protocol was approved by The Joint The Chinese University of Hong Kong–New Territories East Cluster Clinical Research Ethics Committee (Ref. No.: 2021.085 T). Any changes to the protocol will be reported to the Committee. This study is conducted in compliance with the Declaration of Helsinki and the ICH-GCP. Written informed consent will be obtained from all study participants in the trial before enrolment.
: Not applicable.
: None of the authors have any competing interests to declare.